Physician profile
Stella Koretsky
NPI 1487841342
$1,006.77
in general payments reported to CMS, 2019-2025
12 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.03 · 2020: $18.25 · 2021: $166 · 2022: $397 · 2023: $66.66 · 2024: $176 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $353.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $277.71 | 2021-2023 | Wegovy |
| Abbvie INC. | $261.54 | 2022-2025 | |
| Abbott Laboratories | $108.81 | 2022-2025 | Freestyle Libre 3 |
| Allergan, INC. | $85.75 | 2019-2022 | |
| Lilly USA, LLC | $64.61 | 2022-2024 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $55.87 | 2022-2024 | Airsupra, Farxiga |
| Exact Sciences Corporation | $39.88 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $36.57 | 2020-2024 | |
| Amgen INC. | $33.69 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $15.55 | 2025 | Zoryve |
| Sanofi Pasteur INC. | $14.29 | 2019 | |
| Merck Sharp & Dohme LLC | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stella Koretsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.